MUT Gene Variant rs1085308002: Understanding Methylmalonic Acidemia
The rs1085308002 variant is located within the MUT gene, which provides instructions for creating an essential metabolic enzyme. This variant is associated with methylmalonic acidemia, a rare genetic disorder that affects how the body processes certain proteins and fats.
What each genotype means
Typical enzyme function
This genotype represents the most common sequence found in the general population for this specific location in the MUT gene. There is no evidence to suggest this specific genetic sequence contributes to methylmalonic acidemia or altered enzyme activity. You should consult with a healthcare provider if you have specific concerns about metabolic health or family history.
This is the most common genotype observed across global populations.
Carrier status
This genotype indicates you carry one copy of the variant at this position in the MUT gene. While the MUT gene is associated with methylmalonic acidemia, this specific variant is rare and its clinical significance is currently being studied. You should discuss this finding with a genetic counselor or physician to understand its relevance in the context of your overall health and family history.
This genotype is rare and observed at very low frequencies in global population databases.
Potential metabolic variant
This genotype indicates you carry two copies of the variant at this position in the MUT gene. Because the MUT gene is critical for breaking down certain proteins and lipids, variants in this gene can sometimes be linked to methylmalonic acidemia, though the clinical impact of this specific variant remains under investigation. Please consult with a medical professional or metabolic specialist to interpret this result in light of your clinical history.
This genotype is extremely rare in the general population.
What is the rs1085308002 Variant?
The rs1085308002 variant is a specific change in the DNA sequence of the MUT gene, which is located on chromosome 6. In genetics, a variant like this represents a single-letter difference in the genetic code compared to the most common sequence found in the human population. Because the MUT gene is responsible for producing a critical enzyme, changes in its sequence can potentially alter the structure or function of that enzyme. This specific variant is cataloged in clinical databases due to its potential impact on human health. It is important to note that the presence of a variant does not automatically imply a health condition, as many genetic variations are benign. However, because this variant is linked to a known metabolic disorder, it is frequently studied in clinical settings to understand its role in enzyme deficiency.
The Role of the MUT Gene
The MUT gene provides the blueprint for an enzyme called methylmalonyl-CoA mutase. This enzyme acts as a biological catalyst, working in tandem with vitamin B12 to break down specific amino acids, certain types of fats, and cholesterol. When this enzyme functions correctly, it helps the body convert these substances into energy. If the MUT gene contains a variant that prevents the production of a functional enzyme or significantly reduces its activity, the body cannot properly process these metabolic building blocks. This leads to the accumulation of methylmalonic acid and other toxic byproducts in the blood and tissues. This buildup is the hallmark of methylmalonic acidemia, a condition that can cause a range of symptoms depending on how much enzyme activity remains. The severity of the condition is often categorized by whether the enzyme is completely absent or merely reduced in its efficiency.
Research and Clinical Associations
Research into the MUT gene has identified hundreds of variants that contribute to methylmalonic acidemia. The evidence linking specific variants to this condition is generally derived from clinical studies of patients who present with metabolic symptoms. In the case of rs1085308002, it is recognized in clinical databases as a variant of interest regarding methylmalonic acidemia. The strength of evidence for any single variant often depends on how frequently it appears in affected individuals versus the general population. While some variants are well-characterized and known to cause severe forms of the disease, others are rarer and require more extensive functional studies to confirm their impact. Because methylmalonic acidemia is a complex condition with variable clinical presentations, researchers continue to investigate how different MUT variants correlate with the age of onset and the severity of symptoms in affected patients.
Population Frequency and Interpretation
The rs1085308002 variant is classified as rare in the general population. In genetics, rarity is a key indicator that a variant is not a common polymorphism but rather a specific change that may have clinical significance. Because it is rare, it is not typically found in the vast majority of the population. When interpreting genetic information, it is essential to understand that rare variants are often studied in the context of specific families or clinical cohorts where the condition is already present. If you have received information about this variant through genetic testing, it is important to discuss the results with a qualified healthcare provider or a genetic counselor. They can provide context based on your personal and family medical history, as genetic test results are only one piece of a much larger clinical picture.
Managing Genetic Information
Genetic information can be complex, and it is important to approach it with the guidance of medical professionals. If you are concerned about a variant in the MUT gene, a clinician can help determine if further diagnostic testing, such as biochemical screening for methylmalonic acid levels, is appropriate. You cannot diagnose a condition based solely on a single SNP result. Furthermore, if you are taking medications or supplements, always consult with your doctor or pharmacist before making any changes to your health regimen. They can help you understand whether your genetic profile has any implications for your care. Remember that genetic testing is a tool for information, and the most effective way to use that information is in partnership with a healthcare team that understands your unique health needs and history.
How common is this variant?
The rs1085308002 variant is considered rare across global populations, appearing at a very low frequency in standard genomic databases.
Frequently asked questions
What is methylmalonic acidemia?
Methylmalonic acidemia is a rare genetic disorder where the body cannot properly break down certain proteins and fats. This leads to the buildup of toxic substances in the body, which can cause serious health issues if not managed.
Does having a MUT variant mean I have a disease?
No, having a variant does not automatically mean you have a disease. Many genetic variants are harmless, and clinical diagnosis requires a combination of genetic testing, physical exams, and biochemical blood or urine tests.
How is methylmalonic acidemia treated?
Treatment for methylmalonic acidemia is highly individualized and often involves specialized diets, vitamin B12 supplementation, and regular monitoring by metabolic specialists. You must consult with a physician to discuss any medical management.
Should I be worried about my rs1085308002 result?
Genetic results should be interpreted by a healthcare professional who can look at your entire health history. If you are concerned, schedule an appointment with a genetic counselor or a metabolic specialist.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1085308002?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29